Related Experiment Video
Updated: Aug 17, 2025

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.9K
Assessing chemotherapy dosing strategies in a spatial cell culture model
Dhruba Deb1, Shu Zhu1, Michael J LeBlanc1
1Department of Biomedical Engineering, Columbia University, New York, NY, United States.
Frontiers in Oncology
|December 12, 2022
Summary
Optimizing chemotherapy requires predicting patient response. This study used a novel in vitro model and mathematical predictions to show multiple doses decrease cancer cell colony growth more effectively than single doses.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Mathematical Biology
Background:
- Predicting patient response to chemotherapy is a significant challenge in cancer treatment.
- Quantitative models and experimental systems can optimize drug dosage and frequency for improved efficacy.
Purpose of the Study:
- To develop a simple approach for tracking chemo-sensitive and chemoresistant cell populations in 2D colonies.
- To couple experimental observations with computational model predictions for optimizing chemotherapy regimens.
Main Methods:
- Developed 4T1 breast cancer cell lines with varying doxorubicin resistance.
- Tracked 2D cell colony expansion using fluorescence microscopy.
- Built a mathematical model to describe chemo-sensitive and chemoresistant population dynamics.
- Investigated chemotherapy dose and frequency effects on colony growth in vitro.
Main Results:
- Demonstrated heterogeneous cell populations expand within 2D colonies.
- Identified the number of doses that minimize tumor size based on model parameters.
- Showed that multiple chemotherapy doses reduce overall colony growth compared to a single equivalent dose.
Conclusions:
- Multiple chemotherapy doses are more effective than single doses for reducing cancer cell colony growth.
- This in vitro system can be adapted to optimize dosing strategies for heterogeneous cell types and patient-derived cells.
- The combined experimental and computational approach offers a pathway to personalized cancer therapy.

